APS.TO - Aptose Biosciences Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5
183.11M
Enterprise Value 3
143.99M
Trailing P/E
N/A
Forward P/E 1
-5.59
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
6.68
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-7.14

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 317.36%
S&P500 52-Week Change 313.58%
52 Week High 34.0700
52 Week Low 32.0800
50-Day Moving Average 32.8163
200-Day Moving Average 33.0541

Share Statistics

Avg Vol (3 month) 316.34k
Avg Vol (10 day) 321.6k
Shares Outstanding 555.49M
Float 46.86M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct 31, 2019) 4121.33k
Short Ratio (Oct 31, 2019) 46.88
Short % of Float (Oct 31, 2019) 40.30%
Short % of Shares Outstanding (Oct 31, 2019) 40.22%
Shares Short (prior month Sep 30, 2019) 4119.41k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Oct 6, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.04%
Return on Equity (ttm)-120.08%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -20.16M
Net Income Avi to Common (ttm)-24.83M
Diluted EPS (ttm)-0.5530
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.21M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)1.64M
Total Debt/Equity (mrq)5.97
Current Ratio (mrq)7.83
Book Value Per Share (mrq)0.49

Cash Flow Statement

Operating Cash Flow (ttm)-20.83M
Levered Free Cash Flow (ttm)-10.8M